Abstract
The application of multiple drugs or combination chemotherapy for the treatment of cancer has become standard practice since its introduction in the 1960s for the treatment of first testicular cancer and subsequently leukemias and Hodgkin’s disease. Today chemotherapy for malignancies virtually always entails the application of multiple agents, either simultaneously or in some planned sequence. The rationale for combination chemotherapy is based upon the concept of affecting multiple metabolic sites within the tumor cell or multiple points during the tumor cell cycle. At a practical level, the use of non-cross-resistant agents without overlapping toxicity maximizes the effectiveness of such combinations. Recent conceptual advances in the application of cancer chemotherapy have introduced the concept of alternating non-cross-resistant agents applied intensively on a weekly basis. Another conceptual development has been the application of biochemical modulation utilizing a noncytotoxic enhancing agent in conjunction with a primary cytotoxic drug.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Anderson N, Lokich J, Bern M et al. (1989a) Combined 5-fluorouracil administered as a 14-day infusion. Cancer 63: 825–827
Anderson N, Wallach S, Lokich J et al. (1989b) VP16–213 + cisplatinum: 72 hour continuous admixed infusion in 94 patients. ASCO Abs.
Anderson N, Lokich J, Bern M et al. (1989c) A Phase I clinical trial of combined fluoropyrimidines with leuco- vorin in a 14-day infusion. Cancer 6: 233–237
Bargolie B, Smith L, Alexamann R (1984) Effective treatment of advanced multiple myeloma refractory to alkylating agents. N Engl J Med 310: 1353–1356
Creagan E, Richardson R, Kovach J (1988) Pilot study of a continuous five-day intravenous infusion of etoposide concomitant with cisplatin in selected patients with advanced cancer. J Clin Oncol 6: 1197–1201
Kish J, Eusley J, Weaver A et al. (1984) Superior response rate with 96 hours 5FU infusion vs 5FU bolus. PASCO Abs. C-695
Legha SS, Benjamin RS, MacKay B et al. (1982) Role of Adriamycin in breast cancer and sarcomas. In: Muggia FM, Young CW, Carter SK (eds) Anthracycline antibiotics in cancer therapy. Nijhoff, The Hague, pp 432–434
Lokich J (1986) Protracted infusional chemotherapy. In: Lokich J (ed) Cancer chemotherapy by infusion. Precept, Chicago, pp 243–264
Lokich J, Phillips D, Green R et al. (1985) 5-Fluorouracil and methotrexate administered simultaneously as a continuous infusion. Cancer 56: 2395–2398
Lokich J, Zipoli T, Moore C et al. (1986) Doxorubicin/ vinblastine and doxorubicin/cyclophosphamide combination chemotherapy by continuous infusion. Cancer 58: 1020–1023
Lokich J, Anderson N, Bern M et al. (1988) Combined floxuridine and cisplatin in a fourteen day infusion. Cancer 62: 2309–2312
Lokich J et al. (1989a) Cyclophesphamide, methotrexate, and 5-fluorouracil in a three-drug admixture. Cancer 1989: 63: 822–824
Lokich J, Ahlgren J, Gullo J et al. (1989b) A prospective randomized comparison of continuous infusion fluorouracil with a conventional bolus schedule in metastatic colorectal carcinoma: a Mid-Atlantic Oncology Program Study. J Clin Oncol 7: 425–432
Lokich J, Anderson N, Bern M et al. (1989c) Etoposide admixed with cisplatin. Cancer 63: 818–821
Rosenthal J, Adriamycin and bleomycin combination admixture administered by continuous IV infusion alone and concomitantly with radiation therapy. (Protocol activated at Downstate 1988).
Seargeant L, Kobrinsky N, Sus C et al. (1987) In vitro stability and compatability of daunorubicin, cytarabine and etoposide. Cancer Treat Rep 71: 1189–1192
Seifert P, Baker LH, Reed ML et al. (1975) Comparison of continuously infused 5-fluorouracil with bolus injection in treatment of patients with colorectal cancer. Cancer 36: 123–128
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1991 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Lokich, J.J. (1991). Admixtures of Chemotherapy Agents by Continuous Infusion. In: Rotman, M., Rosenthal, C.J. (eds) Concomitant Continuous Infusion Chemotherapy and Radiation. Medical Radiology. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-84186-6_5
Download citation
DOI: https://doi.org/10.1007/978-3-642-84186-6_5
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-84188-0
Online ISBN: 978-3-642-84186-6
eBook Packages: Springer Book Archive